Testing benvitimod cream for skin lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests a cream called benvitimod to see if it helps treat cutaneous T-cell lymphoma, a type of skin lymphoma. It is for adults who have already been diagnosed with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cutaneous T-cell lymphoma (a type of skin lymphoma) through a skin biopsy.
- You are 18 years old or older.
- You are not pregnant, breastfeeding, or planning pregnancy in the next 6 months.
- You have no known allergy to benvitimod cream or its ingredients.
- You do not have severe skin ulcers or active infection where the cream would be applied.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream applied to the skin that may help control early-stage mycosis fungoides, a type of skin lymphoma. It aims to see if the cream can reduce symptoms and slow disease progression without the need for stronger treatments.
This trial is testing a cream called tofacitinib (a type of medicine that helps calm the immune system) for people with early-stage cutaneous T-cell lymphoma (CTCL). The goal is to see if it helps shrink or control the skin lesions safely.
This trial tests a treatment called photopheresis to treat early-stage mycosis fungoides, a type of skin lymphoma. It may help reduce or control skin patches or plaques that have not responded well to standard treatments.
This trial tests a cream containing duvelisib, a drug that may help treat the skin patches of early-stage mycosis fungoides, a type of skin lymphoma. The cream is applied directly to the affected skin to see if it can control the disease.
This study tests whether a special skin care body wash can improve skin lesions in people with mycosis fungoides, a type of skin lymphoma. Researchers will look at skin bacteria before and after using the wash.
This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.
Hear when a new Cutaneous T Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.